EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Orpea's enterprise value is $16,318 Mil.
Orpea's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-3,548 Mil. Therefore, Orpea's EV-to-EBITDA for today is -4.60.
The historical rank and industry rank for Orpea's EV-to-EBITDA or its related term are showing as below:
ORPEF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -4.54 Med: 17.25 Max: 30.12
Current: -4.54
During the past 13 years, the highest EV-to-EBITDA of Orpea was 30.12. The lowest was -4.54. And the median was 17.25.
ORPEF's EV-to-EBITDA is ranked worse than 100% of 460
companies
in the Healthcare Providers & Services industry
Industry Median: 13.06
vs ORPEF: -4.54
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-04), Orpea's stock price is $10.00.
Orpea's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-4331.833. Therefore, Orpea's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Orpea EV-to-EBITDA Historical Data
The historical data trend for Orpea's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Orpea's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orpea's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Orpea's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Orpea's EV-to-EBITDA falls into.
Orpea's current Enterprise Value is $16,318 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Orpea's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-3,548 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orpea (OTCPK:ORPEF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Orpea's share price for today is $10.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Orpea's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-4331.833.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Orpea's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Orpea SA operates a network of long-term, post-acute, psychiatric, and home care facilities in Europe. The majority of the firm's revenue is generated in France. Orpea's long-term care facilities are primarily nursing homes, though it also provides serviced residences for autonomous and semi-autonomous elderly patients. Orpea's post-acute and rehabilitation facilities specialize in geriatrics, musculoskeletal conditions, cardiovascular conditions, nervous system diseases, and, Haematology and oncology. Its psychiatric clinics provide treatment and psychotherapeutic monitoring for a range of conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ORPEF has been successfully added to your 